Clindamycin-hameln Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

clindamycin-hameln

max health limited - clindamycin phosphate 178.23 mg/ml equivalent to clindamycin 150mg/ml - solution for injection - 600 mg/4ml - active: clindamycin phosphate 178.23 mg/ml equivalent to clindamycin 150mg/ml excipient: benzyl alcohol disodium edetate nitrogen sodium hydroxide water for injection - clindamycin phosphate has been shown to be effective in the treatment of the following infections when caused by susceptible anaerobic bacteria or susceptible strains of gram positive bacteria such as streptococci, staphylococci and pneumococci: 1. upper respiratory infections including tonsillitis, pharyngitis, sinusitis, otitis media and scarlet fever.